Literature DB >> 24947599

Male contraception.

Jing Chao1, Stephanie T Page1, Richard A Anderson2.   

Abstract

Clear evidence shows that many men and women would welcome new male methods of contraception, but none have become available. The hormonal approach is based on suppression of gonadotropins and thus of testicular function and spermatogenesis, and has been investigated for several decades. This approach can achieve sufficient suppression of spermatogenesis for effective contraception in most men, but not all; the basis for these men responding insufficiently is unclear. Alternatively, the non-hormonal approach is based on identifying specific processes in sperm development, maturation and function. A range of targets has been identified in animal models, and targeted effectively. This approach, however, remains in the pre-clinical domain at present. There are, therefore, grounds for considering that safe, effective and reversible methods of contraception for men can be developed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  contraception; spermatogenesis; testis; testosterone

Mesh:

Substances:

Year:  2014        PMID: 24947599      PMCID: PMC4707936          DOI: 10.1016/j.bpobgyn.2014.05.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  63 in total

Review 1.  The control of male fertility by spermatozoan ion channels.

Authors:  Polina V Lishko; Yuriy Kirichok; Dejian Ren; Betsy Navarro; Jean-Ju Chung; David E Clapham
Journal:  Annu Rev Physiol       Date:  2011-10-13       Impact factor: 19.318

2.  Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception.

Authors:  Aarnoud C van der Spoel; Mylvaganam Jeyakumar; Terry D Butters; Harry M Charlton; Harry D Moore; Raymond A Dwek; Frances M Platt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

3.  Effects of AF 1312/TS and lonidamine on cultured sertoli cells.

Authors:  M L Marcante; P G Natali; A Floridi; C De Martino
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

4.  Development of dimethandrolone 17beta-undecanoate (DMAU) as an oral male hormonal contraceptive: induction of infertility and recovery of fertility in adult male rabbits.

Authors:  Barbara J Attardi; Jean A Engbring; David Gropp; Sheri Ann Hild
Journal:  J Androl       Date:  2010-12-16

5.  Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men.

Authors:  D Kinniburgh; H Zhu; L Cheng; A T Kicman; D T Baird; R A Anderson
Journal:  Hum Reprod       Date:  2002-06       Impact factor: 6.918

6.  A novel potent indazole carboxylic acid derivative blocks spermatogenesis and is contraceptive in rats after a single oral dose.

Authors:  Joseph S Tash; Barbara Attardi; Sheri A Hild; Ramappa Chakrasali; Sudhakar R Jakkaraj; Gunda I Georg
Journal:  Biol Reprod       Date:  2008-01-23       Impact factor: 4.285

7.  Oral administration of the GnRH antagonist acyline, in a GIPET-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics.

Authors:  John Kenneth Amory; Thomas W Leonard; Stephanie T Page; Edel O'Toole; Michael J McKenna; William J Bremner
Journal:  Cancer Chemother Pharmacol       Date:  2009-05-29       Impact factor: 3.333

Review 8.  Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug.

Authors:  G M Waites; C Wang; P D Griffin
Journal:  Int J Androl       Date:  1998-02

9.  Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.

Authors:  R A Bebb; B D Anawalt; R B Christensen; C A Paulsen; W J Bremner; A M Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

10.  The ability of a gonadotropin-releasing hormone antagonist, acyline, to prevent irreversible infertility induced by the indenopyridine, CDB-4022, in adult male rats: the role of testosterone.

Authors:  Sheri Ann Hild; Barbara J Attardi; Jerry R Reel
Journal:  Biol Reprod       Date:  2004-03-24       Impact factor: 4.285

View more
  9 in total

1.  F5-peptide enhances the efficacy of the non-hormonal male contraceptive adjudin.

Authors:  Haiqi Chen; Dolores Mruk; Chris K C Wong; Bruno Silvestrini; C Yan Cheng
Journal:  Contraception       Date:  2019-02-11       Impact factor: 3.375

Review 2.  Transepithelial transport across the blood-testis barrier.

Authors:  Siennah R Miller; Nathan J Cherrington
Journal:  Reproduction       Date:  2018-12       Impact factor: 3.906

3.  Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier.

Authors:  Raymond K Hau; Joseph S Tash; Gunda I Georg; Stephen H Wright; Nathan J Cherrington
Journal:  J Pharmacol Exp Ther       Date:  2022-07-02       Impact factor: 4.402

Review 4.  Continuing the search for a hormonal male contraceptive.

Authors:  Fiona Yuen; Brian T Nguyen; Ronald S Swerdloff; Christina Wang
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-02-19       Impact factor: 5.237

5.  Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men.

Authors:  Fiona Yuen; Arthi Thirumalai; Cindy Pham; Ronald S Swerdloff; Bradley D Anawalt; Peter Y Liu; John K Amory; William J Bremner; Clint Dart; Hongsheng Wu; Laura Hull; Diana L Blithe; Jill Long; Christina Wang; Stephanie T Page
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

Review 6.  Male hormonal contraception: hope and promise.

Authors:  Katarzyna Piotrowska; Christina Wang; Ronald S Swerdloff; Peter Y Liu
Journal:  Lancet Diabetes Endocrinol       Date:  2016-02-23       Impact factor: 44.867

7.  Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel.

Authors:  F Yuen; S Wu; A Thirumalai; R S Swerdloff; S T Page; P Y Liu; C Dart; H Wu; D L Blithe; R Sitruk-Ware; J Long; F Bai; L Hull; W J Bremner; B D Anawalt; C Wang
Journal:  Andrology       Date:  2018-12-16       Impact factor: 4.456

Review 8.  The future of male contraception: a fertile ground.

Authors:  Iyad Khourdaji; Jacqueline Zillioux; Kevin Eisenfrats; Daniel Foley; Ryan Smith
Journal:  Transl Androl Urol       Date:  2018-05

9.  Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men.

Authors:  Sherry Wu; Fiona Yuen; Ronald S Swerdloff; Youngju Pak; Arthi Thirumalai; Peter Y Liu; John K Amory; Feng Bai; Laura Hull; Diana L Blithe; Bradley D Anawalt; Toufan Parman; Kyuri Kim; Min S Lee; William J Bremner; Stephanie T Page; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 6.134

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.